Soleno Therapeutics Inc.

NASDAQ: SLNO · Real-Time Price · USD
71.63
-5.73 (-7.41%)
At close: Aug 15, 2025, 3:59 PM
71.00
-0.87%
After-hours: Aug 15, 2025, 06:52 PM EDT

Soleno Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
87.93M 169.68M 14.6M 21.3M
Short-Term Investments
203.51M n/a n/a n/a
Long-Term Investments
27.21M n/a n/a n/a
Other Long-Term Assets
83K 165K n/a 40K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.45M 1.68M 1.04M 1.12M
Total Current Assets
293.89M 171.36M 15.65M 22.42M
Property-Plant & Equipment
2.98M 419K 157K 454K
Goodwill & Intangibles
6.8M 8.75M 10.69M 12.64M
Total Long-Term Assets
37.08M 9.33M 10.85M 13.13M
Total Assets
330.97M 180.69M 26.5M 35.55M
Account Payables
8.88M 3.15M 1.78M 3.25M
Deferred Revenue
n/a n/a n/a 4.15M
Short-Term Debt
526K n/a 155K 282K
Other Current Liabilities
9.34M 4.95M 3.55M 769K
Total Current Liabilities
18.75M 11.51M 7.31M 8.01M
Long-Term Debt
49.83M n/a n/a n/a
Other Long-Term Liabilities
14.81M 11.55M 8.84M 9.58M
Total Long-Term Liabilities
67.11M 11.68M 8.84M 9.75M
Total Liabilities
85.86M 23.18M 16.15M 17.76M
Total Debt
52.83M 403K 155K 457K
Common Stock
46K 32K 8K 80K
Retained Earnings
-452.26M -276.41M -237.42M -213.35M
Comprehensive Income
n/a 0.00 n/a -0.00
Shareholders Equity
245.11M 157.51M 10.35M 17.79M
Total Investments
230.72M n/a n/a n/a